In this review we present a proof of concept data, Fig. 4, demonstrating that the expression of PPL, PLEC and EVPL was enhanced in a recurrent HEY ovarian cancer cell line derived mouse xenografts described previously [177]. This evidence concerns the gene PLEC and ovarian cancer.